OBJECTIVES: FTY720 modulates CD4+T cells by the augmentation of regulatory T cell activity. secretion of suppressive cytokines and suppression of IL-17 secretion by Th17 cells. To further understand the process of graft rejection/acceptance. we evaluated skin allograft survival and associated events after FTY720 treatment. https://halohealthcarers.shop/product-category/transport-chairs-wheelchairs/